*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Formulation and evaluation of enteric coated tablet of eluxadoline for the treatment of irritable bowel syndrome

Author: DHERE MANISHA, MAJUMDAR ARTI, MALVIYA NEELESH
Abstract: The purpose of this research work is to formulate enteric coated tablet of eluxadoline for the treatment the irritable bowel syndrome among the aim to increase solubility, oral bioavailability and to achieve target action of drug. Solubility of drug enhanced by the solid dispersion and prepared solid dispersion were evaluated by solubility study, Infra-red spectroscopy, X-Ray diffraction, drug content analysis and in-vitro drug release and further used in the formulation of enteric coated tablet to achieve target action of drug. Eudragit S 100 was used for the enteric coat to tablet. In a total of five batches of formulation from F1 to F5 were prepared via varying concentration of sodium starch glycolate and starch. On the basis of results of evaluation studies revealed that formulation F2 found to be most optimized formulation in terms of good flow properties, hardness, drug content, disintegration time. The enteric coating solution optimized by using Box Behnken design expert software 7.1.6. Optimized formulation exhibited greatest coating character and remained intact for 120 min in 0.1 M HCl and released maximum amount of the drug within the 60 min in phosphate buffer pH 6.8. Studies reveled those coated tablets can be used effectively to target drug delivery.
Keyword: Hydrotropic solid dispersion, Eluxadoline, Sodium caprylate, Eudragit S 100, In-vitro drug release.
DOI: https://doi.org/10.31838/ijpr/2021.13.03.233
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free